Patent · US Active

Substituted pyrimidine compounds, compositions and medicinal applications thereof

US10273224B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2014
Grant dateApr 30, 2019
Priority date
Expiry dateJul 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure relates to pyrimidine compounds of formula (I), their stereoisomers, tautomers, pharmaceutically acceptable salts, polymorphs, solvates, and hydrates thereof. The present disclosure also relates to process of preparation of these pyrimidine compounds, and to pharmaceutical compositions containing them. The compounds of the present disclosure are useful in the treatment, prevention or suppression of diseases and disorders mediated by epidermal growth factor receptor (EGFR) family kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.